Ajanta Pharma Board to Consider Q1 Results and Interim Dividend

Ajanta Pharma Ltd has announced that its Board of Directors will convene on July 30, 2026. The meeting agenda includes the consideration and approval of the unaudited financial results for the first quarter ended June 30, 2026. Additionally, the board will deliberate on the declaration of a first interim dividend for the financial year ending March 31, 2027. The company has also proposed August 5, 2026, as the record date for the payment of this interim dividend, if approved.